Subcellular organization of UBE3A in neurons

Journal of Comparative Neurology

Volumn 525, Issue 2, 2017, Pages 233-251

  Burette, Alain C ^a   Judson, Matthew C ^a   Burette, Susan ^a   Phend, Kristen D ^a   Philpot, Benjamin D ^a   Weinberg, Richard J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Angelman syndrome; axon terminal; E6 AP; euchromatin; heterochromatin; mitochondria; RRID:AB_10740376; RRID:nif 0000 30467; ubiquitin proteasome pathway

Indexed keywords

UBIQUITIN CONJUGATING ENZYME; UBIQUITIN CONJUGATING ENZYME E3A; UNCLASSIFIED DRUG; UBE3A PROTEIN, MOUSE; UBIQUITIN PROTEIN LIGASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CELL NUCLEUS; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ELECTRON MICROSCOPY; GENETIC TRANSCRIPTION; GOLGI COMPLEX; HAPPY PUPPET SYNDROME; IMMUNOCYTOCHEMISTRY; MOLECULAR IMAGING; MOUSE; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SYNAPTIC TRANSMISSION; ANIMAL; BIOSYNTHESIS; BRAIN; C57BL MOUSE; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MALE; METABOLISM; NERVE CELL; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; BRAIN; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; NEURONS; UBIQUITIN-PROTEIN LIGASES;

EID: 85000502063     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.24063     Document Type: Article

References (71)

1. Abrahams BS, Geschwind DH. 2008. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 9:341–355.
2. Acconcia F, Sigismund S, Polo S. 2009. Ubiquitin in trafficking: the network at work. Exp Cell Res 315:1610–1618.
3. Bader N, Jung T, Grune T. 2007. The proteasome and its role in nuclear protein maintenance. Exp Gerontol 42:864–870.
4. Bayes A, Collins MO, Croning MD, van de Lagemaat LN, Choudhary JS, Grant SG. 2012. Comparative study of human and mouse postsynaptic proteomes finds high compositional conservation and abundance differences for key synaptic proteins. PloS one 7:e46683.
5. Bernassola F, Karin M, Ciechanover A, Melino G. 2008. The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell 14:10–21.
6. Cajigas IJ, Will T, Schuman EM. 2010. Protein homeostasis and synaptic plasticity. EMBO J 29:2746–2752.
7. Cao J, Yan Q. 2012. Histone ubiquitination and deubiquitination in transcription, DNA damage response, and cancer. Front Oncol 2:26.
8. Cheng D, Hoogenraad CC, Rush J, Ramm E, Schlager MA, Duong DM, Xu P, Wijayawardana SR, Hanfelt J, Nakagawa T, Sheng M, Peng J. 2006. Relative and absolute quantification of postsynaptic density proteome isolated from rat forebrain and cerebellum. Mol Cell Proteomics 5:1158–1170.
9. Christian SL, Brune CW, Sudi J, Kumar RA, Liu S, Karamohamed S, Badner JA, Matsui S, Conroy J, McQuaid D, Gergel J, Hatchwell E, Gilliam TC, Gershon ES, Nowak NJ, Dobyns WB, Cook EH Jr. 2008. Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder. Biol Psychiatry 63:1111–1117.
10. Collins MO, Husi H, Yu L, Brandon JM, Anderson CN, Blackstock WP, Choudhary JS, Grant SG. 2006. Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome. J Neurochem 97(Suppl 1):16–23.
11. Condon KH, Ho J, Robinson CG, Hanus C, Ehlers MD. 2013. The Angelman syndrome protein Ube3a/E6AP is required for Golgi acidification and surface protein sialylation. J Neurosci 33:3799–3814.
12. Cook EH Jr., Lindgren V, Leventhal BL, Courchesne R, Lincoln A, Shulman C, Lord C, Courchesne E. 1997. Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am J Hum Genet 60:928–934.
13. Dino Rockel T, von Mikecz A. 2002. Proteasome-dependent processing of nuclear proteins is correlated with their subnuclear localization. J Struct Biol 140:189–199.
14. El Hokayem J, Nawaz Z. 2014. E6AP in the brain: one protein, dual function, multiple diseases. Mol Neurobiol 49:827–839.
15. Fabunmi RP, Wigley WC, Thomas PJ, DeMartino GN. 2001. Interferon gamma regulates accumulation of the proteasome activator PA28 and immunoproteasomes at nuclear PML bodies. J Cell Sci 114:29–36.
16. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S, Zhang H, Estes A, Brune CW, Bradfield JP, Imielinski M, Frackelton EC, Reichert J, Crawford EL, Munson J, Sleiman PM, Chiavacci R, Annaiah K, Thomas K, Hou C, Glaberson W, Flory J, Otieno F, Garris M, Soorya L, Klei L, Piven J, Meyer KJ, Anagnostou E, Sakurai T, Game RM, Rudd DS, Zurawiecki D, McDougle CJ, Davis LK, Miller J, Posey DJ, Michaels S, Kolevzon A, Silverman JM, Bernier R, Levy SE, Schultz RT, Dawson G, Owley T, McMahon WM, Wassink TH, Sweeney JA, Nurnberger JI, Coon H, Sutcliffe JS, Minshew NJ, Grant SF, Bucan M, Cook EH, Buxbaum JD, Devlin B, Schellenberg GD, Hakonarson H. 2009. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459:569–573.
17. Goo MS, Scudder SL, Patrick GN. 2015. Ubiquitin-dependent trafficking and turnover of ionotropic glutamate receptors. Front Mol Neurosci 8:60.
18. Greer PL, Hanayama R, Bloodgood BL, Mardinly AR, Lipton DM, Flavell SW, Kim TK, Griffith EC, Waldon Z, Maehr R, Ploegh HL, Chowdhury S, Worley PF, Steen J, Greenberg ME. 2010. The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 140:704–716.
19. Gustin RM, Bichell TJ, Bubser M, Daily J, Filonova I, Mrelashvili D, Deutch AY, Colbran RJ, Weeber EJ, Haas KF. 2010. Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome. Neurobiol Dis 39:283–291.
20. Ham A, Kim DW, Kim KH, Lee SJ, Oh KB, Shin J, Mar W. 2013. Reynosin protects against neuronal toxicity in dopamine-induced SH-SY5Y cells and 6-hydroxydopamine-lesioned rats as models of Parkinson's disease: reciprocal up-regulation of E6-AP and down-regulation of alpha-synuclein. Brain Res 1524:54–61.
21. Hamilton AM, Zito K. 2013. Breaking it down: the ubiquitin proteasome system in neuronal morphogenesis. Neural Plast 2013:196848.
22. Heck DH, Zhao Y, Roy S, LeDoux MS, Reiter LT. 2008. Analysis of cerebellar function in Ube3a-deficient mice reveals novel genotype-specific behaviors. Hum Mol Genet 17:2181–2189.
23. Hegde AN. 2004. Ubiquitin–proteasome-mediated local protein degradation and synaptic plasticity. Prog Neurobiol 73:311–357.
24. Hogart A, Leung KN, Wang NJ, Wu DJ, Driscoll J, Vallero RO, Schanen NC, LaSalle JM. 2009. Chromosome 15q11-13 duplication syndrome brain reveals epigenetic alterations in gene expression not predicted from copy number. J Med Genet 46:86–93.
25. Hogart A, Wu D, LaSalle JM, Schanen NC. 2010. The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13. Neurobiol Dis 38:181–191.
26. Iossifov I, O'Roak BJ, Sanders SJ, Ronemus M, Krumm N, Levy D, Stessman HA, Witherspoon KT, Vives L, Patterson KE, Smith JD, Paeper B, Nickerson DA, Dea J, Dong S, Gonzalez LE, Mandell JD, Mane SM, Murtha MT, Sullivan CA, Walker MF, Waqar Z, Wei L, Willsey AJ, Yamrom B, Lee YH, Grabowska E, Dalkic E, Wang Z, Marks S, Andrews P, Leotta A, Kendall J, Hakker I, Rosenbaum J, Ma B, Rodgers L, Troge J, Narzisi G, Yoon S, Schatz MC, Ye K, McCombie WR, Shendure J, Eichler EE, State MW, Wigler M. 2014. The contribution of de novo coding mutations to autism spectrum disorder. Nature 515:216–221.
27. Jensen PH, Nielsen MS, Jakes R, Dotti CG, Goedert M. 1998. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J Biol Chem 273:26292–26294.
28. Jiang YH, Armstrong D, Albrecht U, Atkins CM, Noebels JL, Eichele G, Sweatt JD, Beaudet AL. 1998. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21:799–811.
29. Jiang YH, Pan Y, Zhu L, Landa L, Yoo J, Spencer C, Lorenzo I, Brilliant M, Noebels J, Beaudet AL. 2010. Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3. PloS One 5:e12278.
30. Judson MC, Sosa-Pagan JO, Del Cid WA, Han JE, Philpot BD. 2014. Allelic specificity of Ube3a expression in the mouse brain during postnatal development. J Comp Neur 522:1874–1896.
31. Kishino T, Lalande M, Wagstaff J. 1997. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet 15:70–73.
32. Kovac J, Macedoni Luksic M, Trebusak Podkrajsek K, Klancar G, Battelino T. 2014. Rare single nucleotide polymorphisms in the regulatory regions of the superoxide dismutase genes in autism spectrum disorder. Autism Res 7:138–144.
33. Landers M, Bancescu DL, Le Meur E, Rougeulle C, Glatt-Deeley H, Brannan C, Muscatelli F, Lalande M. 2004. Regulation of the large (approximately 1000 kb) imprinted murine Ube3a antisense transcript by alternative exons upstream of Snurf/Snrpn. Nucleic Acids Res 32:3480–3492.
34. Le Meur E, Watrin F, Landers M, Sturny R, Lalande M, Muscatelli F. 2005. Dynamic developmental regulation of the large noncoding RNA associated with the mouse 7C imprinted chromosomal region. Dev Biol 286:587–600.
35. Li J, Shi M, Ma Z, Zhao S, Euskirchen G, Ziskin J, Urban A, Hallmayer J, Snyder M. 2014. Integrated systems analysis reveals a molecular network underlying autism spectrum disorders. Mol Syst Biol 10:774.
36. Li Q, Lau A, Morris TJ, Guo L, Fordyce CB, Stanley EF. 2004. A syntaxin 1, Galpha(o), and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization. J Neurosci 24:4070–4081.
37. Llewellyn KJ, Nalbandian A, Gomez A, Wei D, Walker N, Kimonis VE. 2015. Administration of CoQ10 analogue ameliorates dysfunction of the mitochondrial respiratory chain in a mouse model of Angelman syndrome. Neurobiol Dis 76:77–86.
38. Margolis SS, Salogiannis J, Lipton DM, Mandel-Brehm C, Wills ZP, Mardinly AR, Hu L, Greer PL, Bikoff JB, Ho HY, Soskis MJ, Sahin M, Greenberg ME. 2010. EphB-mediated degradation of the RhoA GEF Ephexin5 relieves a developmental brake on excitatory synapse formation. Cell 143:442–455.
39. Margolis SS, Sell GL, Zbinden MA, Bird LM. 2015. Angelman syndrome. Neurotherapeutics 12:641–650.
40. Maroteaux L, Campanelli JT, Scheller RH. 1988. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8:2804–2815.
41. Matsumoto Y, Nakagawa S, Yano T, Takizawa S, Nagasaka K, Nakagawa K, Minaguchi T, Wada O, Ooishi H, Matsumoto K, Yasugi T, Kanda T, Huibregtse JM, Taketani Y. 2006. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6. J Med Virol 78:501–507.
42. Matsuura T, Sutcliffe JS, Fang P, Galjaard RJ, Jiang YH, Benton CS, Rommens JM, Beaudet AL. 1997. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet 15:74–77.
43. Miao S, Chen R, Ye J, Tan GH, Li S, Zhang J, Jiang YH, Xiong ZQ. 2013. The Angelman syndrome protein Ube3a is required for polarized dendrite morphogenesis in pyramidal neurons. J Neurosci 33:327–333.
44. Mishra A, Maheshwari M, Chhangani D, Fujimori-Tonou N, Endo F, Joshi AP, Jana NR, Yamanaka K. 2013. E6-AP association promotes SOD1 aggresomes degradation and suppresses toxicity. Neurobiol Aging 34:1310 e1311–1323.
45. Miura K, Kishino T, Li E, Webber H, Dikkes P, Holmes GL, Wagstaff J. 2002. Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice. Neurobiol Dis 9:149–159.
46. Mulherkar SA, Jana NR. 2010. Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome. Neurobiol Dis 40:586–592.
47. Mulherkar SA, Sharma J, Jana NR. 2009. The ubiquitin ligase E6-AP promotes degradation of alpha-synuclein. J Neurochem 110:1955–1964.
48. + exchanger isoforms are distributed to Golgi and post-Golgi compartments and are involved in organelle pH regulation. J Biol Chem 280:1561–1572.
49. Nawaz Z, Lonard DM, Smith CL, Lev-Lehman E, Tsai SY, Tsai MJ, O'Malley BW. 1999. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol Cell Biol 19:1182–1189.
50. Nielsen SV, Poulsen EG, Rebula CA, Hartmann-Petersen R. 2014. Protein quality control in the nucleus. Biomolecules 4:646–661.
51. Osley MA, Fleming AB, Kao CF. 2006. Histone ubiquitylation and the regulation of transcription. Results Problems Cell Differ 41:47–75.
52. Pal P, Lochab S, Kanaujiya JK, Kapoor I, Sanyal S, Behre G, Trivedi AK. 2013. E3 ubiquitin ligase E6AP negatively regulates adipogenesis by downregulating proadipogenic factor C/EBPalpha. PloS One 8:e65330.
53. Pescosolido MF, Stein DM, Schmidt M, El Achkar CM, Sabbagh M, Rogg JM, Tantravahi U, McLean RL, Liu JS, Poduri A, Morrow EM. 2014. Genetic and phenotypic diversity of NHE6 mutations in Christianson syndrome. Ann Neurol 76:581–593.
54. Reid G, Hubner MR, Metivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J, Gannon F. 2003. Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol Cell 11:695–707.
55. Rivett AJ, Palmer A, Knecht E. 1992. Electron microscopic localization of the multicatalytic proteinase complex in rat liver and in cultured cells. J Histochem Cytochem 40:1165–1172.
56. Rougeulle C, Glatt H, Lalande M. 1997. The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain. Nat Genet 17:14–15.
57. Santini E, Turner KL, Ramaraj AB, Murphy MP, Klann E, Kaphzan H. 2015. Mitochondrial superoxide contributes to hippocampal synaptic dysfunction and memory deficits in angelman syndrome model mice. J Neurosci 35:16213–16220.
58. Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675.
59. Schwarz LA, Patrick GN. 2012. Ubiquitin-dependent endocytosis, trafficking and turnover of neuronal membrane proteins. Mol Cell Neurosci 49:387–393.
60. Stromme P, Dobrenis K, Sillitoe RV, Gulinello M, Ali NF, Davidson C, Micsenyi MC, Stephney G, Ellevog L, Klungland A, Walkley SU. 2011. X-linked Angelman-like syndrome caused by Slc9a6 knockout in mice exhibits evidence of endosomal–lysosomal dysfunction. Brain 134:3369–3383.
61. Su H, Fan W, Coskun PE, Vesa J, Gold JA, Jiang YH, Potluri P, Procaccio V, Acab A, Weiss JH, Wallace DC, Kimonis VE. 2011. Mitochondrial dysfunction in CA1 hippocampal neurons of the UBE3A deficient mouse model for Angelman syndrome. Neurosci Lett 487:129–133.
62. Tai HC, Schuman EM. 2008. Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction. Nat Rev Neurosci 9:826–838.
63. Takamori S, Holt M, Stenius K, Lemke EA, Gronborg M, Riedel D, Urlaub H, Schenck S, Brugger B, Ringler P, Muller SA, Rammner B, Grater F, Hub JS, De Groot BL, Mieskes G, Moriyama Y, Klingauf J, Grubmuller H, Heuser J, Wieland F, Jahn R. 2006. Molecular anatomy of a trafficking organelle. Cell 127:831–846.
64. Tsang CK, Liu Y, Thomas J, Zhang Y, Zheng XF. 2014. Superoxide dismutase 1 acts as a nuclear transcription factor to regulate oxidative stress resistance. Nat Commun 5:3446.
65. van Woerden GM, Harris KD, Hojjati MR, Gustin RM, Qiu S, de Avila Freire R, Jiang YH, Elgersma Y, Weeber EJ. 2007. Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of alphaCaMKII inhibitory phosphorylation. Nat Neurosci 10:280–282.
66. Vu TH, Hoffman AR. 1997. Imprinting of the Angelman syndrome gene, UBE3A, is restricted to brain. Nat Genet 17:12–13.
67. Wallace ML, Burette AC, Weinberg RJ, Philpot BD. 2012. Maternal loss of Ube3a produces an excitatory/inhibitory imbalance through neuron type-specific synaptic defects. Neuron 74:793–800.
68. Weeber EJ, Jiang YH, Elgersma Y, Varga AW, Carrasquillo Y, Brown SE, Christian JM, Mirnikjoo B, Silva A, Beaudet AL, Sweatt JD. 2003. Derangements of hippocampal calcium/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome. J Neurosci 23:2634–2644.
69. Yamamoto Y, Huibregtse JM, Howley PM. 1997. The human E6-AP gene (UBE3A) encodes three potential protein isoforms generated by differential splicing. Genomics 41:263–266.
70. Yashiro K, Riday TT, Condon KH, Roberts AC, Bernardo DR, Prakash R, Weinberg RJ, Ehlers MD, Philpot BD. 2009. Ube3a is required for experience-dependent maturation of the neocortex. Nat Neurosci 12:777–783.
71. Yi JJ, Berrios J, Newbern JM, Snider WD, Philpot BD, Hahn KM, Zylka MJ. 2015. An autism-linked mutation disables phosphorylation control of UBE3A. Cell 162:795–807.